First patients to test experimental blood cancer drug

NCT ID NCT07441694

Recruiting now Disease control Sponsor: Incyte Corporation Source: ClinicalTrials.gov ↗

Summary

This is the first study in people to test a new drug called INCA036978 for myeloproliferative neoplasms, a group of rare blood cancers. The main goal is to find a safe dose and understand the drug's side effects in up to 218 participants with myelofibrosis, polycythemia vera, or essential thrombocythemia. Researchers will give the drug alone and combined with standard therapy to see how the body processes it and if it helps control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

A. Gemelli University Hospital, Catholic University of the Sacred Heart
NOT_YET_RECRUITING

Roma, 00168, Italy
AZ DELTA
NOT_YET_RECRUITING

Roeselare, 08800, Belgium
Aou Policlinico S. Orsola-Malpighi
NOT_YET_RECRUITING

Bologna, 40138, Italy
Azienda Sanitaria Universitaria Friuli Centrale Asu Fc
NOT_YET_RECRUITING

Udine, 33100, Italy
Centre Hospitalier Universitaire (Chu) de Liege
NOT_YET_RECRUITING

Liège, 04000, Belgium
Charite Universitaetsmedizin Berlin - Campus Charite Mitte
NOT_YET_RECRUITING

Berlin, 10117, Germany
City of Hope-Lennar Foundation Cancer Center
NOT_YET_RECRUITING

Irvine, California, 92618, United States
Cleveland Clinic
NOT_YET_RECRUITING

Cleveland, Ohio, 44195, United States
Concord General Repatriation Hospital
NOT_YET_RECRUITING

Concord, New South Wales, 02139, Australia
Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy
NOT_YET_RECRUITING

Durham, North Carolina, 27705, United States
Epworth Health Care
RECRUITING

East Melbourne, Victoria, 03002, Australia
Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico
NOT_YET_RECRUITING

Milan, 20122, Italy
Guy'S Hospital - Guy'S & St Thomas' Nhs Foundation Trust
NOT_YET_RECRUITING

London, SE1 9RT, United Kingdom
Hospital Saint Louis
NOT_YET_RECRUITING

Paris, 75010, France
Hospital Universitari Germans Trias I Pujol
NOT_YET_RECRUITING

Badalona, 08916, Spain
Hospital Universitario 12 de Octubre
NOT_YET_RECRUITING

Madrid, 28041, Spain
Hospital Universitario de Gran Canaria Dr. Negrin
NOT_YET_RECRUITING

Las Palmas de Gran Canaria, 35010, Spain
Huntsman Cancer Institute
NOT_YET_RECRUITING

Salt Lake City, Utah, 84112, United States
Icon Cancer Centre
RECRUITING

Auchenflower, Queensland, 04066, Australia
Institut Bergonie
NOT_YET_RECRUITING

Bordeaux, 33076, France
John Hopkins Hospital
NOT_YET_RECRUITING

Baltimore, Maryland, 21287, United States
Levine Cancer Institute
NOT_YET_RECRUITING

Charlotte, North Carolina, 28204, United States
Linear Clinical Research
NOT_YET_RECRUITING

Nedlands, Western Australia, 06009, Australia
Massachusetts General Hospital
NOT_YET_RECRUITING

Boston, Massachusetts, 02114, United States
Medical College of Wisconsin
NOT_YET_RECRUITING

Milwaukee, Wisconsin, 53226, United States
Moffitt Cancer Center
NOT_YET_RECRUITING

Tampa, Florida, 33612, United States
Mount Sinai School of Medicine
NOT_YET_RECRUITING

New York, New York, 10029, United States
Nottingham University Hospitals
NOT_YET_RECRUITING

Nottingham, NG5 1PB, United Kingdom
Ohio State University
NOT_YET_RECRUITING

Columbus, Ohio, 43210, United States
Royal North Shore Hospital
NOT_YET_RECRUITING

St Leonards, New South Wales, 02065, Australia
Tristar Bmt/Tcto
NOT_YET_RECRUITING

Nashville, Tennessee, 37203, United States
UCLA Medical Hematology & Oncology
NOT_YET_RECRUITING

Los Angeles, California, 90095, United States
Universitatklinikum Freiburg
NOT_YET_RECRUITING

Freiburg im Breisgau, 79106, Germany
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii
NOT_YET_RECRUITING

Mainz, 55131, Germany
University Medical Center Rwth Aachen
NOT_YET_RECRUITING

Aachen, D-52074, Germany
University of Alabama At Birmingham
NOT_YET_RECRUITING

Birmingham, Alabama, 35233, United States
University of Miami
NOT_YET_RECRUITING

Miami, Florida, 33136, United States
University of North Carolina At Chapel Hill
NOT_YET_RECRUITING

Chapel Hill, North Carolina, 27514, United States
University of Oxford
NOT_YET_RECRUITING

Oxford, OX3 7LE, United Kingdom
University of Texas M. D. Anderson Cancer Center
NOT_YET_RECRUITING

Houston, Texas, 77030, United States
Usc Norris Comprehensive Cancer Center
NOT_YET_RECRUITING

Los Angeles, California, 90033, United States
Washington University School of Medicine
NOT_YET_RECRUITING

St Louis, Missouri, 63108, United States
Weill Cornell Medicine
NOT_YET_RECRUITING

New York, New York, 10065, United States
Winship Cancer Institute of Emory University
NOT_YET_RECRUITING

Atlanta, Georgia, 30322, United States
Yale Cancer Center
NOT_YET_RECRUITING

New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.

MYELOPROLIFERATIVE NEOPLASMS